Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
<h4>Background</h4>Routine screening for nontuberculous mycobacterial (NTM) lung disease is dependent on sputum cultures. This is particularly challenging in the cystic fibrosis (CF) population due to reduced sputum production and low culture sensitivity. Biomarkers of infection that do...
Saved in:
| Main Authors: | Kara M Calhoun, Emily Armantrout, Katie Poch, Silvia Caceres, Valerie K Lovell, Marion Jones, Kenneth C Malcolm, Brian Vestal, Emily Wheeler, Noel Rysavy, Jordan Manzer, Ibrahim Aboellail, Delphi Chatterjee, Jerry A Nick |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0309191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterium avium DNA extraction: Implications for NTM identification and amplicon sequencing
by: Christoffel J. Opperman, et al.
Published: (2025-05-01) -
Optimizing the Journey for Patients With Nontuberculous Mycobacterial (NTM) Lung Disease in the United Kingdom
by: Fiona McDonald, et al.
Published: (2025-08-01) -
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
by: Marc Lipman, et al.
Published: (2020-12-01) -
Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
by: Birgit Schramm, et al.
Published: (2021-01-01) -
Granulomatous Mediastinal Lymphadenitis Due to *M. avium* Infection with Progression to Systemic NTM Disease: A Case Report
by: Claudia Weber, et al.
Published: (2025-06-01)